Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1000-1007

  Pan, Hong ^a   Sheng, Jian Zhong ^b   Tang, Li ^a   Zhu, Rong ^a   Zhou, Tian Hua ^a   Huang, He Feng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

c fos; endometriosis; MMP 9; pathogenesis

Indexed keywords

GELATINASE B; PROTEIN C FOS;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MENSTRUAL CYCLE; MIDDLE AGED; OVARIAN DISEASES; PROTO-ONCOGENE PROTEINS C-FOS; UP-REGULATION;

EID: 52949142278     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.07.1386     Document Type: Article

References (39)

1. Cramer D.W., and Missmer S.A. The epidemiology of endometriosis. Ann N Y Acad Sci 955 (2002) 11-22 discussion 34-6, 396-406
2. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-469
3. Gaetje R., Kotzian S., Herrmann G., Baumann R., and Starzinski-Powitz A. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol 150 (1997) 461-467
4. Giudice L.C., Tazuke S.I., and Swiersz L. Status of current research on endometriosis. J Reprod Med 43 Suppl 3 (1998) 252-262
5. Gaetje R., Kotzian S., Herrmann G., Baumann R., and Starzinski-Powitz A. Invasiveness of endometriotic cells in vitro. Lancet 346 (1995) 1463-1464
6. Katori H., Nozawa A., and Tsukuda M. Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma. J Surg Oncol 93 (2006) 80-85
7. Lakka S.S., Gondi C.S., Dinh D.H., Olivero W.C., Gujrati M., Rao V.H., et al. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 280 (2005) 21882-21892
8. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 41 (2005) 2449-2461
9. Rajapakse N., Kim M.M., Mendis E., Huang R., and Kim S.K. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1. Biochim Biophys Acta 1760 (2006) 1780-1788
10. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4 (1993) 197-250
11. Goffin F., Munaut C., Frankenne F., Perrier D'Hauterive S., Beliard A., Fridman V., et al. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod 69 (2003) 976-984
12. Chung H.W., Lee J.Y., Moon H.S., Hur S.E., Park M.H., Wen Y., et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 78 (2002) 787-795
13. Lu X.E., Ning W.X., Dong M.Y., Liu A.X., Jin F., and Huang H.F. Vascular endothelial growth factor and matrix metalloproteinase-2 expedite formation of endometriosis in the early stage ICR mouse model. Fertil Steril 86 Suppl 4 (2006) 1175-1181
14. Kitawaki J., Kado N., Ishihara H., Koshiba H., Kitaoka Y., and Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 83 (2002) 149-155
15. Olive D.L., and Pritts E.A. The treatment of endometriosis: a review of the evidence. Ann N Y Acad Sci 955 (2002) 360-372 discussion 389-93, 396-406
16. Vercellini P., Cortesi I., and Crosignani P.G. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 68 (1997) 393-401
17. Weisz A., and Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18 (1990) 5097-5106
18. Hyder S.M., Stancel G.M., Nawaz Z., McDonnell D.P., and Loose-Mitchell D.S. Identification of an estrogen response element in the 3Vflanking region of the murine c-fos protooncogene. J Biol Chem 267 (1992) 18047-18054
19. Reis F.M., Maia A.L., Ribeiro M.F., and Spritzer P.M. Progestin modulation of c-fos and prolactin gene expression in the human endometrium. Fertil Steril 71 (1999) 1125-1132
20. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279 (2004) 27008-27016
21. Jochum W., Passegue E., and Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene 20 (2001) 2401-2412
22. Han S., Ritzenthaler J.D., Sitaraman S.V., and Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281 (2006) 29614-29624
23. Chen X., Su Y., Fingleton B., Acuff H., Matrisian L.M., Zent R., et al. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int J Cancer 116 (2005) 52-61
24. Hiratsuka S., Nakamura K., Iwai S., Murakami M., Itoh T., Kijima H., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2 (2002) 289-300
25. van Kempen L.C., and Coussens L.M. MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2 (2002) 251-252
26. Collette T., Maheux R., Mailloux J., and Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod 21 (2006) 3059-3067
27. Chung H.W., Wen Y., Chun S.H., Nezhat C., Woo B.H., and Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 75 (2001) 152-159
28. Collette T., Bellehumeur C., Kats R., Maheux R., Mailloux J., Villeneuve M., et al. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 19 (2004) 1257-1264
29. Nair R.R., and Boyd D.D. Expression cloning of novel regulators of 92 kDa type IV collagenase expression. Biochem Soc Trans 33 (2005) 1135-1136
30. Milde-Langosch K., Roder H., Andritzky B., Aslan B., Hemminger G., Brinkmann A., et al. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat 86 (2004) 139-152
31. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67 (1997) 817-821
32. Gresz V., Kwon T.H., Hurley P.T., Varga G., Zelles T., Nielsen S., et al. Identification and localization of aquaporin water channels in human salivary glands. Am J Physiol Gastrointest Liver Physiol 281 (2001) G247-G254
33. Cai J., Lou H.Y., Dong M.Y., Lu X.E., Zhu Y.M., Huang H.F., et al. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells. Fertil Steril 87 (2007) 1350-1356
34. Hastings J.M., Jackson K.S., Mavrogianis P.A., and Fazleabas A.T. The estrogen early response gene FOS is altered in a baboon model of endometriosis. Biol Reprod 75 (2006) 176-182
35. Mendoza-Rodriguez C.A., Camacho-Arroyo I., Garcia G.A., and Cerbon M.A. Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites. Contraception 59 (1999) 339-343
36. Hudelist G., Keckstein J., Czerwenka K., Lass H., Walter I., Auer M., et al. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril 84 Suppl 2 (2005) 1249-1256
37. Uzan C., Cortez A., Dufournet C., Fauvet R., Siffroi J.P., and Daraï E. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2. Virchows Arch 445 (2004) 603-609
38. Dufournet C., Uzan C., Fauvet R., Cortez A., Siffroi J.P., and Darai E. Expression of apoptosis-related proteins in peritoneal, ovarian and colorectal endometriosis. J Reprod Immunol 70 (2006) 151-162
39. Sharpe-Timms K.L., and Cox K.E. Paracrine regulation of matrix metalloproteinase expression in endometriosis. Ann N Y Acad Sci 955 (2002) 147-156 discussion 157-8, 396-406